Pinned Tweet
We are turning this account into a fully automated page.
To learn more about what’s going on at Immunity, please follow us on LinkedIn! linkedin.com/company/immunit…
Online now: The transcription factor TOX maintains stemness circuits that sustain longevity and multipotency of progenitor CD4+ T cells in chronic infection dlvr.it/TWMs1C
Online now: Brain border-associated macrophages rhythmically scavenge amyloid-beta and regulate vascular amyloid pathology dlvr.it/TWMkrb
Online now: Human interferon-α autoantibody development broadens reactivity and enables functional synergy dlvr.it/TWKGnP
Be part of three days of science, discussion, and connection with Tak Mak @UofT and the international neuroimmunology community at #CPSNeuroImmune27 @NYAMNYC.
Abstract deadline: April 30, 2027
hubs.li/Q04F6KQK0
3
2,297
Online now: Granzyme K is a driver of age-related tissue remodeling and functional decline independently of age-associated immune dysfunction dlvr.it/TWJW3v
Immunity retweeted
Looking for a home for your neuroscience research? Chat to Kavitha Scranton, scientific editor at @ImmunityCP. She’ll be happy to discuss publishing opportunities and tell you why Immunity could be a good fit for your work. Book an online meeting: hubs.li/Q04DzxCk0
#SfN26
Immunity retweeted
🔔 Check out this #OpenAccess @ImmunityCP review providing an overview of the current applications, the challenges and limitations, and future avenues of human brain cellular #xenografts in neuroimmunology and translational research!
🔗 bit.ly/4zvDjIJ
Share the stage with researchers including Chengcheng Jin @PennMedicine at #CPSNeuroImmune27 in New York.
Submit your abstract by April 30, 2027, for the opportunity to be part of the program.
hubs.ly/Q04DKHtx0
Discover the latest research from Vinny Augustine @UCSanDiego and an outstanding international community at #CPSNeuroImmune27 in New York.
Abstract deadline: April 30, 2027
hubs.li/Q04DyPVC0
Immunity retweeted
1) 📢 New study out in @ImmunityCP : We show that tumor-to-cDC1 reprogramming induces tertiary lymphoid structures (TLSs) across cancers. Read it here:sciencedirect.com/science/ar…. A thread 🧵
#TLS #reprogramming #immunotherapy
Graphical abstract by Avesta Rastan.
Online now: Tumor-to-dendritic cell reprogramming induces immunogenic lymphoid structures across cancers dlvr.it/TWBfLG
Online now: Mitochondrial DNA abundance is a determinant of immunogenic cell death in cancer dlvr.it/TW6zH0
Online now: Growth factor VEGF-B sustains intestinal Tfh cell stemness to restrict Taurinivorans outgrowth and microbiota-driven obesity dlvr.it/TW6F82
Immunity retweeted
Efficacy of PD-L1×4-1BB antibodies relies on PD-L1+ cDC1, which integrate antigen cross-presentation, IL-12, & 4-1BB costimulation to promote efficacious T cell-mediated antitumor immunity
cell.com/immunity/abstract/S… @ImmunityCP @DrIgMelero
@ClinicaNavarra @Teijeira_ITLive 🇪🇸
Immunity retweeted
PD-L1 on B cell zone reticular cells, including follicular dendritic cells, promotes humoral immunity by restraining a subset of Tfh that promotes Tfr development @ImmunityCP @eakamagarren @BostonChildrens
cell.com/immunity/abstract/S…
Online now: T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody dlvr.it/TW5dCV
Online now: PD-L1 expression in germinal centers promotes humoral immunity by restricting T follicular regulatory cell differentiation dlvr.it/TW5W2b
Hear from keynotes Ardem Patapoutian @ardemp @scrippsresearch & Gloria Choi @MIT at #CPSNeuroImmune27 in New York @NYAMNYC and share your own research with the neuroimmunology community.
Abstract deadline: April 30, 2027
hubs.li/Q04CtNzQ0
2
1,483
Online now: A microbiome-reactive TMIGD2hi Th17 subset is spatially enriched at the intestinal epithelium and expanded in inflammatory bowel disease dlvr.it/TW48GH

























